CLBS119 for Repair of COVID-19 Induced Pulmonary Damage

Summary

This clinical trial will explore the safety and potential efficacy of CLBS119 for the repair of COVID-19 induced pulmonary damage in adults.

Timeline

Start

2020-10-05

Primary completion

2021-05

Completion

2021-05

Outcome

Outcome not reported

Stopped: “Acute COVID-19 treatments have improved significantly leading to decreased use of ventilatory support. This, coupled with approval of a vaccine, has changed the profile/prognosis of patients and led to a lack of patients with long-term hypoxia.”

Drugs

Indications